APG-157

· Aveta Biomics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for APG-157, covering 2024-08-09 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of APG-157 in Head and Neck Cancer [Phase 2]